A RESPONSE TO A RECENT EDITORIAL BY CONCERNED PHYSICIANS ON 3,4-DIAMINOPYRIDINE

被引：0
|
作者：
McEnany, Patrick J. [1 ]
机构：
[1] Catalyst Pharmaceut Inc, Coral Gables, FL 33134 USA
来源：
MUSCLE & NERVE | 2017年 / 55卷 / 01期
关键词：
D O I：
10.1002/mus.25437
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] EDITORIAL BY CONCERNED PHYSICIANS: UNINTENDED EFFECT OF THE ORPHAN DRUG ACT ON THE POTENTIAL COST OF 3,4-DIAMINOPYRIDINE
    Burns, Ted M.
    Smith, Gordon A.
    Allen, Jeffrey A.
    Amato, Anthony A.
    Arnold, W. David
    Barohn, Richard
    Benatar, Michael
    Bird, Shawn J.
    Bromberg, Mark
    Chahin, Nizar
    Ciafaloni, Emma
    Cohen, Jeffrey A.
    Corse, Andrea
    Crum, Brian A.
    David, William S.
    Dimberg, Elliot
    De Sousa, Eduardo A.
    Donofrio, Peter D.
    Dyck, P. James B.
    Engel, Andrew G.
    Ensrud, Erik R.
    Ferrante, Mark
    Freimer, Miriam
    Gable, Karissa L.
    Gibson, Summer
    Gilchrist, James M.
    Goldstein, Jonathan M.
    Gooch, Clifton L.
    Goodman, Brent P.
    Gorelov, Dmitri
    Gospe, Sidney M., Jr.
    Goyal, Namita A.
    Guidon, Amanda C.
    Guptill, Jeffrey T.
    Gutmann, Laurie
    Gutmann, Ludwig
    Gwathmey, Kelly
    Harati, Yadollah
    Harper, C. Michel, Jr.
    Hehir, Michael K.
    Hobson-Webb, Lisa D.
    Howard, James F., Jr.
    Jackson, Carlayne E.
    Johnson, Nicholas
    Jones, Sarah M.
    Juel, Vern C.
    Kaminski, Henry J.
    Karam, Chafic
    Kennelly, Kathleen D.
    Khella, Sami
    MUSCLE & NERVE, 2016, 53 (02) : 165 - 168
  • [2] 3,4-diaminopyridine
    Rubin-Preminger, Janice M.
    Englert, Ulli
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O757 - O758
  • [3] PHARMACOLOGY OF 3,4-DIAMINOPYRIDINE
    VOHRA, MM
    PRADHAN, SN
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1964, 150 (3-4): : 413 - &
  • [4] Treatment of severe botulism with 3,4-diaminopyridine
    Dock, M
    Ben Ali, A
    Karras, A
    Misset, B
    Garrouste-Orgeas, M
    Deletie, E
    Goldstein, F
    Carlet, J
    PRESSE MEDICALE, 2002, 31 (13): : 601 - 602
  • [5] Pharmacokinetics and Tissue Distribution of 3,4-Diaminopyridine
    Komai, Kiyonobu
    Matsushita, Ryo
    Kondo, Yuya
    Ishida, Natsuko
    Ishida, Chiho
    NEUROLOGY, 2011, 76 (09) : A282 - A282
  • [6] EFFECT OF 3,4-DIAMINOPYRIDINE ON ENDPLATE RECEPTOR DESENSITIZATION
    PAVANI, NJP
    VITALBRAZIL, O
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1982, 15 (2-3) : 196 - 196
  • [7] Effect of 3,4-diaminopyridine at the murine neuromuscular junction
    Ng, Fiona
    Lee, Diana C.
    Schrumpf, Leah A.
    Mazurek, Mary E.
    Lee, Victoria
    Gill, Sharleen K.
    Maselli, Ricardo A.
    MUSCLE & NERVE, 2017, 55 (02) : 223 - 231
  • [8] 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF CONGENITAL (HEREDITARY) MYASTHENIA
    PALACE, J
    WILES, CM
    NEWSOMDAVIS, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (12): : 1069 - 1072
  • [9] Pharmacokinetics and tissue distribution of 3,4-diaminopyridine in rats
    Ishida, Natsuko
    Kondo, Yuya
    Chikano, Yuri
    Kobayashi-Nakade, Erina
    Suga, Yukio
    Ishizaki, Junko
    Komai, Kiyonobu
    Matsushita, Ryo
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2019, 40 (08) : 294 - 301
  • [10] 3,4-DIAMINOPYRIDINE IN DEMYELINATING PERIPHERAL NEUROPATHIES - REPLY
    BERGIN, PS
    MILLER, DH
    HIRSCH, NP
    MURRAY, NMF
    ANNALS OF NEUROLOGY, 1994, 36 (03) : 453 - 453
12345